Download and print this flier by clicking on the image below. See the bottom of this page for additional manufacturer details.
Additional Manufacturer Details
Novo Nordisk
- Review Cencora’s notice about the WAC Decrease
- Review Novo Nordisk’s notice about the WAC Decrease
- The rebate calculation will be (current WAC minus lower WAC) * 0.98
- Be mindful of this statement from Novo Nordisk: “Eligible pharmacy purchases during the specified period will be monitored to limit excessive ordering […] purchases will be managed against each pharmacy’s recent historical purchasing behavior.”
Boehringer Ingelheim
- Review Boehringer Ingelheim’s FAQs about the WAC Decrease
- The rebate calculation will be (QTY invoiced between 12/13/26 and 12/26/26 – QTY rebated through MFP) * (old purchase price – new purchase price).
- Tradjenta is on the IRA drug list for January 1, 2027. For Part D Tradjenta dispenses, you will be refunded the difference between (2027) WAC and MFP. If you raise a Good Faith Inquiry (GFI) through the MFP rebate process to receive an MFP refund based on the 2026 WAC, these units will be excluded from the rebate program to avoid duplication.
- The purchase price is the lower of either (i) WAC or (ii) the contract price.
